Fink Eric

CIK 00017840381 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001784038

Recent Transactions

25 trades

Purchase
Global Blood Therapeutics, Inc.
Common Stock
2021-05-10$37.96/sh+500→ 5,161 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2021-03-01$44.48/sh−859→ 4,661 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-03-01−3,125→ 15,625 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-01+38,739→ 38,739 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-03-01+22,102→ 22,102 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-03-01+3,125→ 5,520 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-02-01+3,020→ 3,342 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2021-02-01$49.49/sh−947→ 2,395 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2021-02-01$42.60/sh+322→ 322 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-02-01−3,020→ 18,120 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-10-05$60.00/sh−4,532→ 0 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2020-09-01$60.45/sh−1,718→ 4,532 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-09-01+6,250→ 6,250 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-09-01−6,250→ 18,750 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-08-05$69.32/sh−1,504→ 950 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-08-05$70.10/sh−950→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-08-01−3,020→ 21,140 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-08-01+3,020→ 3,283 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2020-08-01$67.48/sh−829→ 2,454 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2020-07-31$55.47/sh+263→ 263 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-06-01+42,400→ 42,400 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-03+38,500→ 38,500 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-02-03+24,160→ 24,160 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2019-09-01+25,000→ 25,000 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2019-09-01+38,000→ 38,000 total

Companies

Global Blood Therapeutics, Inc.
Chief Human Resources Officer

Recent Filings

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 171 OYSTER POINT BLVD., SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov